The Prognosis Podcast by Emversity

The Prognosis Episode 20 | Building India’s MedTech Powerhouse: The BPL 2.0 Vision

Emversity Podcast Season 1 Episode 20

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 1:26:50

“There’s so much clinical need here. If you can solve for India, you can solve for the world.”

Solving healthcare in India isn’t easy but for Dr. Shravan Subramanyam, that’s exactly what makes it a compelling challenge to take on.

In this episode of The Prognosis Podcast, Dr. Shravan Subramanyam, MD and Group CEO of BPL Medical Technologies, shares the thinking behind BPL 2.0 and its ambition to scale 10x in 10 years.

Drawing from leadership stints across global healthcare giants, he unpacks what it takes to build a homegrown MedTech company in a market long dominated by imports, from owning IP and manufacturing to expanding into global markets.

In this episode:
- Why Dr. Shravan chose to return to India and build in one of healthcare’s toughest markets
- The strategic vision behind BPL 2.0 and its 10x in 10 years ambition
- Moving from product trading to IP ownership and manufacturing control
- BPL balancing affordability with clinical reliability
- Reducing India’s import dependence in medical devices
- The global opportunity for India-built MedTech across emerging markets

Follow Us:
Instagram: https://www.instagram.com/emversity/?hl=en
LinkedIn: / the-prognosis-podcast 
Twitter: https://x.com/emversity